India-US trade deal: Win-win or one-sided deal?
India-US trade deal: Win-win or one-sided deal?
- 100
- 08
As the nation battles the second wave of Covid-19, the Drugs Controller General of India (DCGI) has finally approved Bharat Biotech to conduct Covaxin's Phase 2-3 clinical trials on children between the age of 2 and 18 years.
Bharat Biotech will conduct the clinical trials on 525 healthy volunteers in the below 18 age group.
And now, with Covid cases being reported among children, parents are anxious about vaccine for kids. So, when will vaccine for kids arrive? Will it be the same vaccine as that given to adults? Will vaccine for kids be safe? Could vaccine be mandatory for kids to return to schools?
Watch as panelists share their thoughts on these and more on the show.
India-US trade deal: Win-win or one-sided deal?
I would like to interview PM Modi: Tucker Carlson
Maharashtra man kills daughter to contest panchayat elections
Trump versus Modi: Who blinked first? Experts debate